Aspire Shares Are Trading Higher Monday: What's Going On?

Benzinga·08/18/2025 19:18:06

Listen to the news

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) shares are trading higher Monday after the company announced top-line data from its crossover bioavailability trial assessing its investigational new sublingual aspirin product compared to chewed uncoated aspirin tablets in healthy adults.

What To Know: The company said its new under-the-tongue aspirin product for suspected heart attacks worked faster and more effectively than standard chewed aspirin in the study. The treatment was safe and well-tolerated, with no side effects reported.

"We are extremely pleased to report these highly positive results for our sublingual aspirin formulation, providing an important validation of our drug delivery technology," said Kraig Higginson, CEO of Aspire. "The ability to achieve higher and more rapid aspirin concentrations for patients with suspected heart attacks could save lives."

Aspire said it plans to review the results with the FDA to support a potential application for accelerated approval.

ASBP Price Action: At the time of writing, Aspire shares are trading 80.67% higher at 65 cents, according to data from Benzinga Pro.

Image via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English